PHIAN Stock Chart & Stats
$479.54
$0.00(0.00%)
At close: 4:00 PM EDT
$479.54
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$330.00 - $504.33
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$498.69B
Enterprise Value$28.72B
Total Cash (Recent Filing)$1.79B
Total Debt (Recent Filing)$7.46B
Price to Earnings (P/E)20.8
Beta0.47
Next Earnings
Nov 03, 2026EPS Estimate
7.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.17
Shares Outstanding982,884,770
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.11
Price to Book (P/B)2.01
Price to Sales (P/S)1.24
P/FCF Ratio24.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$496.40Price Target Upside3.51% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)34.22
Revenue Forecast (FY)$377.56B
Bulls Say, Bears Say
Bulls Say
Operational RecoveryThe return to positive earnings alongside double-digit TTM revenue growth indicates renewed demand and operating recovery after prior declines. A solid EBIT margin provides a base for reinvestment and service expansion, although durability still depends on consistent execution.
Manageable LeverageManageable leverage and equity exceeding total debt provide Philips with financial resilience while it funds product development and customer programs. Stable debt-to-equity over time also reduces the risk that normal operating volatility will sharply constrain strategic flexibility.
Recurring Healthcare RevenuePhilips combines equipment sales with maintenance, upgrades, software, consumables, and multi-year solution arrangements. This installed-base model can support repeat purchasing and recurring revenue, making customer relationships and cash generation more durable than one-time equipment sales alone.
Bears Say
Free Cash Flow DeteriorationThe sharp decline in free cash flow growth weakens confidence that recent earnings are translating into steadily improving cash generation. Historically uneven cash flow, including negative operating and free cash flow in 2022, suggests conversion may remain vulnerable to working-capital or restructuring swings.
Earnings VolatilityThe recovery in profitability is encouraging, but the recent loss-making period and five-year earnings volatility make current performance less clearly durable. Net and operating margins also remain below the 2021 peak, limiting confidence that the rebound represents a fully normalized earnings base.
Prior Balance-sheet PressureThe decline in equity from 2021 and several years of negative returns show that earlier earnings pressure affected the balance sheet and shareholder returns. Although ROE has recovered, the recent turnaround still needs to persist before Philips can demonstrate consistently stronger capital productivity.
Koninklijke Philips N.V. News
PHIAN FAQ
What was Koninklijke Philips N.V.’s price range in the past 12 months?
Koninklijke Philips N.V. lowest stock price was $330.00 and its highest was $504.33 in the past 12 months.
What is Koninklijke Philips N.V.’s market cap?
Koninklijke Philips N.V.’s market cap is $498.69B.
When is Koninklijke Philips N.V.’s upcoming earnings report date?
Koninklijke Philips N.V.’s upcoming earnings report date is Nov 03, 2026 which is in 4 days.
How were Koninklijke Philips N.V.’s earnings last quarter?
Koninklijke Philips N.V. released its earnings results on Jul 27, 2026. The company reported $10.186 earnings per share for the quarter, beating the consensus estimate of $7.317 by $2.869.
Is Koninklijke Philips N.V. overvalued?
According to Wall Street analysts Koninklijke Philips N.V.’s price is currently Undervalued.
Does Koninklijke Philips N.V. pay dividends?
Koninklijke Philips N.V. does not currently pay dividends.
What is Koninklijke Philips N.V.’s EPS estimate?
Koninklijke Philips N.V.’s EPS estimate is 7.13.
How many shares outstanding does Koninklijke Philips N.V. have?
Koninklijke Philips N.V. has 982,884,770 shares outstanding.
What happened to Koninklijke Philips N.V.’s price movement after its last earnings report?
Koninklijke Philips N.V. reported an EPS of $10.186 in its last earnings report, beating expectations of $7.317. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Koninklijke Philips N.V.?
Currently, no hedge funds are holding shares in MX:PHIAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasound) solutions, crucial for diagnosis, treatment planning, and guidance in areas like cardiology, general imaging, obstetrics/gynecology, and point-of-care settings. This segment is further supported by proprietary software platforms designed to facilitate diagnostics and interventions, as well as enterprise diagnostic informatics products and related services. The Connected Care division focuses on solutions for critical patient management, emergency response, and sleep and respiratory conditions. Additionally, it delivers electronic medical record (EMR) and broader care management platforms. For Personal Health, Philips provides a range of consumer products, encompassing oral hygiene solutions such as electric toothbrushes, brush heads, and interdental cleaning and teeth whitening systems. This segment also includes infant feeding and digital parenting solutions, along with male grooming and beauty devices. Philips actively pursues strategic collaborations to enhance its offerings, notably partnering with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company also maintains a strategic partnership agreement with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the company adopted its current name, Koninklijke Philips N.V., in May 2013, having previously operated as Koninklijke Philips Electronics N.V.
PHIAN Stock 12 Month Forecast
Average Price Target
$496.40
▲(3.51% Upside)